Controlling Ebola outbreaks presents significant challenges due to the virus's high mortality rate, the lack of specific treatment, and the complex sociopolitical environments in affected regions. Weak healthcare infrastructures, cultural practices, and community mistrust can hinder response efforts. International collaboration, rapid deployment of resources, and community engagement are critical. The 2014-2016 West African Ebola epidemic underscored the importance of global preparedness. Efforts were intensified to develop vaccines, resulting in the approval of rVSV-ZEBOV-GP, an effective Ebola vaccine. However, challenges persist in ensuring equitable access to vaccines and addressing community hesitancy. Ongoing research aims to understand the virus's persistence in survivors, potential animal reservoirs, and to develop antiviral therapies. Strengthening surveillance systems, improving diagnostic capabilities, and enhancing coordination between nations are integral components of global preparedness to mitigate the impact of future Ebola outbreaks.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain